Arbutus Biopharma and Vaccitech Announce Clinical Trial Collaboration Agreement to Evaluate RNAi Therapeutic, AB-729, in Combination with Immunotherapeutic, VTP-300, in Subjects with Chronic Hepatitis B Virus – chatter @ #wallstreetbets

By
Mehabe
-
0
429

Arbutus Biopharma and Vaccitech Announce Clinical Trial Collaboration Agreement to Evaluate RNAi Therapeutic, AB-729, in Combination with Immunotherapeutic, VTP-300, in Subjects with Chronic Hepatitis B Virus
https://investor.arbutusbio.com/news-releases/news-release-details/arbutus-biopharma-and-vaccitech-announce-clinical-trial

This site uses Akismet to reduce spam. Learn how your comment data is processed.